 Connection
James Falko to Triglycerides
This is a "connection" page, showing publications James Falko has written about Triglycerides.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.213 |
|
|
|
-
Falko JM, Moser RJ, Meis SB, Caulin-Glaser T. Cardiovascular disease risk of type 2 diabetes mellitus and metabolic syndrome: focus on aggressive management of dyslipidemia. Curr Diabetes Rev. 2005 May; 1(2):127-35.
Score: 0.053
-
Falko JM, O'Dorisio TM, Cataland S. Spurious elevations in glycosylated hemoglobin (HbA1) secondary to hypertriglyceridemia. Arch Intern Med. 1982 Jul; 142(7):1370-1.
Score: 0.043
-
Glueck CJ, Streicher P, Wang P, Sprecher D, Falko JM. Treatment of severe familial hypertriglyceridemia during pregnancy with very-low-fat diet and n-3 fatty acids. Nutrition. 1996 Mar; 12(3):202-5.
Score: 0.028
-
La Londe MA, Graffagnino CL, Falko JM, Snow RJ, Spencer K, Caulin-Glaser T. Effect of a weight management program on the determinants and prevalence of metabolic syndrome. Obesity (Silver Spring). 2008 Mar; 16(3):637-42.
Score: 0.016
-
Falko JM, Parr JH, Simpson RN, Wynn V. Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations. Am J Med. 1987 Oct; 83(4):641-7.
Score: 0.016
-
Patel ST, Newman HA, Yates AJ, Thibert P, Falko JM. Serum lipids and lipoprotein composition in spontaneously diabetic BB Wistar rats. J Lipid Res. 1984 Oct; 25(10):1072-83.
Score: 0.013
-
Falko JM, Schonfeld G, Witztum JL, Kolar JB, Salmon P. Effects of short-term high carbohydrate, fat-free diet on plasma levels of Apo C-II and Apo C-III and on the Apo C subspecies in human plasma lipoproteins. Metabolism. 1980 Jul; 29(7):654-61.
Score: 0.009
-
Falko JM, Schonfeld G, Witztum JL, Kolar J, Weidman SW. Effects of estrogen therapy on apolipoprotein E in type II hyperlipoproteinemia. Metabolism. 1979 Nov; 28(11):1171-7.
Score: 0.009
-
Falko JM, Witztum JL, Schonfeld G, Bateman J. Dietary treatment of type V hyperlipoproteinemia fails to normalize low levels of high-density lipoprotein cholesterol. Ann Intern Med. 1979 Nov; 91(5):750-1.
Score: 0.009
-
Falko JM, Williams JC, Harvey DG, Weidman SW, Schonfeld G, Dodson WE. Hyperlipoproteinemia and multifocal neurologic dysfunction in systemic lupus erythematosus. J Pediatr. 1979 Oct; 95(4):523-9.
Score: 0.009
-
Falko JM, Witztum JL, Schonfeld G, Weidman SW, Kolar JB. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy. Am J Med. 1979 Feb; 66(2):303-10.
Score: 0.009
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|